Prof Gary Anderson
Professor
Department of Biochemistry and Pharmacology
324 Scholarly works
64 Projects
HIGHLIGHTS
2026
Journal article
Participant experience of a low-carbon, hybrid 'spoke-and-hub', small-format lung health conference.
DOI: 10.1093/atsscholar/aapag0302026
Journal article
Biomarkers of Pre-COPD Lung Function Trajectories in Middle Age: A Prospective Study From 1st to 6th Decade
DOI: 10.1002/resp.702792026
Journal article
Association of blood eosinophils and exhaled nitric oxide with exacerbations in patients with asthma, COPD and asthma COPD: the NOVELTY study
DOI: 10.1136/thorax-2025-2236462025
Journal article
CURE Asthma: a unique opportunity for Australia
DOI: 10.5694/mja2.700932025
Research grants (ARC, NHMRC, MRFF)
Does Inhaled Triple Therapy in Individuals With Pre-Copd Arrest Progression to Full-Blown COPD? A Double-Blind Randomised Placebo-Controlled Trial (PRE-TREAT)
2022
Research Grant
Implementing a Nurse-Enabled, Shared-Care Model to Address Unmet Needs of People With Neuroendocrine Tumours: The AUS-NE
2022
Research grants (ARC, NHMRC, MRFF)
Intranasal TLR2/6 Activation to Prevent COVID Infection in the Elderly
RECENT SCHOLARLY WORKS
2025
Journal article
Evidence from Australian cohort studies about asthma trajectories and transitions across the life course: a narrative review
DOI: 10.5694/mja2.700862025
Journal article
Technological advances in the search for a CURE for asthma
DOI: 10.5694/mja2.700842025
Journal article
Finding cures for asthma: new paradigms for drug discovery and therapy
DOI: 10.5694/mja2.700892025
Journal article
The CURE Asthma roadmap
DOI: 10.5694/mja2.700942025
Journal article
VEGF-D Protects the Lung in Neonatal Hyperoxia-induced Lung Injury
DOI: 10.1165/rcmb.2024-0544OC2025
Journal article
Reframing remission in severe asthma: a conceptual framework for distinguishing disease activity versus damage
DOI: 10.1016/S2213-2600(25)00299-1
RECENT PROJECTS
2026
Research grants (ARC, NHMRC, MRFF)
The CURE Asthma Data Integration Research Engine (CURE-ADIRE)
2025
Research grants (ARC, NHMRC, MRFF)
Targeting JAG-1 for Mucosecretory Diseases